These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis. Molnar MZ, Streja E, Sumida K, Soohoo M, Ravel VA, Gaipov A, Potukuchi PK, Thomas F, Rhee CM, Lu JL, Kalantar-Zadeh K, Kovesdy CP. Clin J Am Soc Nephrol; 2017 Sep 07; 12(9):1428-1437. PubMed ID: 28679562 [Abstract] [Full Text] [Related]
4. Left ventricular hypertrophy and left atrial diameter are associated with mortality risk in haemodialysis patients: a retrospective cohort study. Bai J, Huang W, Zhang Y, Wei L, Zhao C, Ren Z, Wang Q, Ren K, Cao N. Clin Exp Nephrol; 2024 Jul 07; 28(7):683-691. PubMed ID: 38457031 [Abstract] [Full Text] [Related]
5. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients. Tian JP, Wang T, Wang H, Cheng LT, Tian XK, Lindholm B, Axelsson J, Du FH. Ren Fail; 2008 Jul 07; 30(4):391-400. PubMed ID: 18569912 [Abstract] [Full Text] [Related]
6. Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction. Ganda A, Weiner SD, Chudasama NL, Valeri AM, Jadoon A, Shimbo D, Radhakrishnan J. Clin Nephrol; 2012 May 07; 77(5):366-75. PubMed ID: 22551882 [Abstract] [Full Text] [Related]
7. Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population. Soliman EZ, Shah AJ, Boerkircher A, Li Y, Rautaharju PM. Circ Arrhythm Electrophysiol; 2014 Jun 07; 7(3):400-6. PubMed ID: 24762807 [Abstract] [Full Text] [Related]
8. The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis. Hsieh HL, Hsu SC, Cheng HS, Chen CY, Huang WC, Sue YM, Lin FY, Shih CM, Chen JW, Lin SJ, Huang PH, Liu CT. PLoS One; 2020 Jun 07; 15(1):e0228405. PubMed ID: 31999778 [Abstract] [Full Text] [Related]
9. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care. Ravera M, Noberasco G, Signori A, Re M, Filippi A, Cannavò R, Weiss U, Cricelli C, Deferrari G, Paoletti E. Am J Hypertens; 2013 May 07; 26(5):700-7. PubMed ID: 23391620 [Abstract] [Full Text] [Related]
10. Dialysis versus Medical Management at Different Ages and Levels of Kidney Function in Veterans with Advanced CKD. Kurella Tamura M, Desai M, Kapphahn KI, Thomas IC, Asch SM, Chertow GM. J Am Soc Nephrol; 2018 Aug 07; 29(8):2169-2177. PubMed ID: 29789430 [Abstract] [Full Text] [Related]
11. Association of outcome with left ventricular parameters measured by two-dimensional and three-dimensional echocardiography in patients at high cardiovascular risk. Stanton T, Jenkins C, Haluska BA, Marwick TH. J Am Soc Echocardiogr; 2014 Jan 07; 27(1):65-73. PubMed ID: 24161481 [Abstract] [Full Text] [Related]
12. The prognostic value of electrocardiographic estimation of left ventricular hypertrophy in dialysis patients. Covic AC, Buimistriuc LD, Green D, Stefan A, Badarau S, Kalra PA. Ann Noninvasive Electrocardiol; 2013 Mar 07; 18(2):188-98. PubMed ID: 23530490 [Abstract] [Full Text] [Related]
13. Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease. de Roij van Zuijdewijn CL, Hansildaar R, Bots ML, Blankestijn PJ, van den Dorpel MA, Grooteman MP, Kamp O, ter Wee PM, Nubé MJ. Am J Nephrol; 2015 Mar 07; 42(2):126-33. PubMed ID: 26382055 [Abstract] [Full Text] [Related]
14. Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease. Krishnasamy R, Isbel NM, Hawley CM, Pascoe EM, Burrage M, Leano R, Haluska BA, Marwick TH, Stanton T. PLoS One; 2015 Mar 07; 10(5):e0127044. PubMed ID: 25978372 [Abstract] [Full Text] [Related]
15. GFR at initiation of dialysis and mortality in CKD: a meta-analysis. Susantitaphong P, Altamimi S, Ashkar M, Balk EM, Stel VS, Wright S, Jaber BL. Am J Kidney Dis; 2012 Jun 07; 59(6):829-40. PubMed ID: 22465328 [Abstract] [Full Text] [Related]
16. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L. Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):352-7. PubMed ID: 22566286 [Abstract] [Full Text] [Related]
17. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients. Unver S, Kavlak E, Gümüsel HK, Celikbilek F, Esertas K, Muftuoglu T, Kirilmaz A. Ren Fail; 2015 Jul 01; 37(6):951-6. PubMed ID: 26030798 [Abstract] [Full Text] [Related]
18. Left Ventricular Hypertrophy (LVH) and Left Ventricular Geometric Patterns in Patients with Chronic Kidney Disease (CKD) Stage 2-5 With Preserved Ejection Fraction (EF): A Systematic Review to Explore CKD Stage-wise LVH Patterns. Maqbool S, Shafiq S, Ali S, Rehman MEU, Malik J, Lee KY. Curr Probl Cardiol; 2023 Apr 01; 48(4):101590. PubMed ID: 36632930 [Abstract] [Full Text] [Related]
19. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, Sanderson JE. J Am Soc Nephrol; 2004 Aug 01; 15(8):2186-94. PubMed ID: 15284304 [Abstract] [Full Text] [Related]
20. Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents. Hayashi T, Kimura T, Yasuda K, Obi Y, Sasaki K, Iio K, Miyasato K, Kamimura T, Kitamura H, Tsubakihara Y, Rakugi H, Isaka Y. Clin Exp Nephrol; 2013 Apr 01; 17(2):294-303. PubMed ID: 23100176 [Abstract] [Full Text] [Related] Page: [Next] [New Search]